argenx SE (EBR:ARGX)
Belgium · Delayed Price · Currency is EUR 767.00
0.00 (0.00%)
Aug 11, 2026, 12:41 PM CET
argenx SE Market Cap
argenx SE has a market cap or net worth of €47.97 billion as of August 11, 2026. Its market cap has increased by 37.89% in one year.
Market Cap
47.97B
Enterprise Value
43.47B
Revenue
4.65B
Ranking
n/a
PE Ratio
33.43
Stock Price
€767.00
ChartMarket Cap Chart
Since July 10, 2014, argenx SE's market cap has increased from 122.42M to 47.97B, an increase of 39,081.52%. That is a compound annual growth rate of 63.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 47.97B | 9.34% |
| Dec 31, 2025 | 43.87B | 21.11% |
| Dec 31, 2024 | 36.22B | 78.48% |
| Dec 29, 2023 | 20.29B | 5.32% |
| Dec 30, 2022 | 19.27B | 18.28% |
| Dec 31, 2021 | 16.29B | 42.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 42.92B |
| Financière de Tubize | 8.52B |
| Onward Medical | 161.65M |
| Hyloris Pharmaceuticals | 126.84M |
| European Medical Solutions | 17.01M |
| Celyad Oncology | 12.09M |
| BioSenic | 1.31M |
| Oxurion NV | 248.34K |